|
x
|
Preliminary
Information Statement
|
|
¨
|
Confidential, for Use of the
Commission Only (as permitted by Rule
14c-5(d)(2))
|
|
¨
|
Definitive
Information Statement
|
|
x
|
No
fee required.
|
|
¨
|
Fee
computed below per Exchange Act Rules 14c-5(g) and
0-11.
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
(2)
|
Aggregate
number of securities to which transaction
applies:
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was
determined):
|
|
(4)
|
Proposed
maximum aggregate value of
transaction:
|
|
(5)
|
Total
fee paid:
|
|
¨
|
Fee
paid previously with preliminary
materials.
|
|
1)
|
Amount
Previously Paid:
|
|
2)
|
Form,
Schedule or Registration Statement
No.:
|
|
3)
|
Filing
Party:
|
|
4)
|
Date
Filed:
|
|
By
Order of the Board of Directors
|
|
|
/s/
Peter Giacalone
|
|
|
Peter
Giacalone
Chairman
of the Board
|
|
|
October 29,
2010
|
|
|
·
|
136,778,330
shares of our Common Stock;
|
|
·
|
265,237
shares of Series B Preferred Stock convertible into 13,261,850 shares of
Common Stock;
|
|
·
|
17,871,940
options outstanding (8,937,192 of which are vested) to purchase shares of
Common Stock at a weighted average exercise price of $2.31;
and
|
|
·
|
8,703,572
warrants outstanding (6,713,186 of which are vested) to purchase shares of
Common Stock at a weighted average exercise price of
$1.50.
|
|
·
|
The
reverse split will qualify as a recapitalization for U.S. federal income
tax purposes. As a result:
|
|
·
|
Stockholders
should not recognize any gain or loss as a result of the reverse
split.
|
|
·
|
The
aggregate basis of a stockholder’s pre-reverse split shares will become
the aggregate basis of the shares held by such stockholder immediately
after the reverse split.
|
|
·
|
The
holding period of the shares owned immediately after the reverse split
will include the stockholder’s holding period before the reverse
split.
|
|
·
|
each
of our directors, executive officers and our executive officers and
directors as a group; and
|
|
·
|
each
person owning of record or known by us, based on information provided to
us by the persons named below, to own beneficially at least 5% of our
Common Stock;
|
|
Total Number of
|
||||||||||||||||
|
Shares of Common
|
Percentage
|
|||||||||||||||
|
Stock Post
|
Ownership
|
|||||||||||||||
|
Conversion of
|
Post
|
|||||||||||||||
|
Preferred Stock and
|
Conversion
|
|||||||||||||||
|
Common
|
Series B
|
Exercise of Options
|
and
|
|||||||||||||
|
Holder
|
Stock
|
Preferred
|
and Warrants (1)
|
Exercise
|
||||||||||||
|
Sector
Performance Fund, LP (a)
|
87,454,886 | 219,144 | 98,412,086 | (2) | 66.61 | % | ||||||||||
|
HM
Unitek Coinvest, LLP (a)
|
13,319,640 | - | 13,319,640 | (3) | 9.74 | % | ||||||||||
|
SPF
SBS LP (a)
|
5,525,574 | 13,847 | 6,217,924 | (4) | 4.52 | % | ||||||||||
|
Peter
Brodsky, Director
|
106,300,100 | 232,991 | 117,949,650 | (5) | 79.47 | % | ||||||||||
|
Joe
Colonnetta, Director
|
106,300,100 | 232,991 | 117,949,650 | (6) | 79.47 | % | ||||||||||
|
Daniel
Hopkin, Director
|
- | - | - | (7) | N/A | |||||||||||
|
Richard
B. Berliner, Director and Chief Marketing Officer
|
7,522,964 | - | 7,522,964 | (8) | 5.50 | % | ||||||||||
|
Old
Berliner Liquidating Trust
|
13,101,644 | - | 13,101,644 | (9) | 9.58 | % | ||||||||||
|
Sigma
Opportunity Fund, LLC
|
7,844,789 | - | 8,019,789 | (10) | 5.86 | % | ||||||||||
|
C.
Scott Hisey, Director and Chief Executive Officer
|
1,200,000 | 1,000 | 4,076,350 | (11) | 2.92 | % | ||||||||||
|
Peter
Giacalone, Executive Chairman
|
1,100,000 | 2,667 | 2,433,350 | (12) | 1.76 | % | ||||||||||
|
Ronald
Lejman, Chief Financial Officer and Treasurer
|
- | - | 400,000 | (13) | * | |||||||||||
|
Dan
Yannantuono, CEO DirectSat
|
75,000 | 172 | 731,826 | (14) | * | |||||||||||
|
Chris
Perkins, CEO FTS USA
|
- | - | 193,650 | (15) | * | |||||||||||
|
Scott
Lochhead, CEO Advanced Communications LLC
|
- | - | 520,000 | (16) | * | |||||||||||
|
Elizabeth
Downey, Chief Administration Officer
|
25,000 | 58 | 503,280 | (17) | * | |||||||||||
|
Kyle
Hall, General Counsel and Secretary
|
- | - | - | - | - | |||||||||||
|
Nicholas
Day, Former General Counsel
|
||||||||||||||||
|
and
Secretary
|
30,696 | - | 165,696 | (18) | * | |||||||||||
|
Dean
MacDonald, Director
|
500,000 | 1,146 | 607,300 | (19) | * | |||||||||||
|
Mark
S. Dailey, Director
|
54,166 | - | 104,166 | (20) | * | |||||||||||
|
Richard
Siber, Director
|
- | - | - | * | ||||||||||||
|
Raymond
A. Cardonne, Jr., former Chief Financial Officer and Treasurer of
BCI
|
- | - | 50,000 | (21) | * | |||||||||||
|
Michael
S. Gurriero, former Chief
|
||||||||||||||||
|
Operating
Officer of BCI
|
- | - | 527,500 | (22) | * | |||||||||||
|
Peter
Mixter, Former Director
|
25,000 | - | 75,167 | (23) | * | |||||||||||
|
Mehran
Nazari, Former Director
|
54,166 | - | 104,166 | (20) | * | |||||||||||
|
John
Stevens Robling, Jr., Former Director
|
25,000 | - | 75,167 | (23) | * | |||||||||||
|
Thom
Waye, Former Director
|
7,844,789 | - | 8,019,789 | (24) | 5.86 | % | ||||||||||
|
Executive
Officers amd Directors as a Group (nineteen persons)
(25)
|
124,756,881 | 238,034 | 144,060,021 | (26) | 92.30 | % | ||||||||||
|
(a)
|
Address
is c/o HM Capital, 200 Crescent Ct, Suite 1600, Dallas, Texas
75201.
|
|
(1)
|
For
purposes of this column, a person is deemed to have beneficial ownership
of the number of shares of Common Stock and Preferred Stock that such
person has the right to acquire within 60 days of October 29,
2010. Percentages have been based on 136,778,330 shares of
Common Stock outstanding. For purposes of computing the
percentage of outstanding shares of Common Stock held by any individual
listed in this table, any shares of Common Stock that such person has the
right to acquire pursuant to the conversion of the Company’s Series B
Preferred Stock, along with the exercise of stock options or warrants
exercisable within 60 days of October 29, 2010, is deemed to be
outstanding, but is not deemed to be outstanding for the purpose of
computing the percentage ownership of any other
person.
|
|
(2)
|
Sector
Performance Fund, LP (“Sector Performance Fund”) is the direct beneficial
owner of 98,412,086 shares of Common Stock, consisting of
(i) 87,454,866 shares of Common Stock and (ii) 10,957,200 shares
of Common Stock issuable upon the conversion of 219,144 shares of Series B
Preferred Stock, each share of which is convertible into 50 shares of
Common Stock, subject to customary structural anti-dilution adjustments
for stock splits, dividends and similar events, upon the option of the
holder. Sector Performance GP, LP (“Sector Performance GP”) is
the general partner of Sector Performance Fund. As a result,
Sector Performance GP may be deemed to share beneficial ownership with
respect to these securities. Sector Performance LLC (“Ultimate
GP”) is the general partner of Sector Performance GP and, as a result,
Ultimate GP may be deemed to share beneficial ownership with respect to
these securities. Except to the extent of any pecuniary
interests, each of Sector Performance GP and Ultimate GP disclaims the
existence of such beneficial ownership. A six-person committee
(consisting of Joe Colonnetta, Peter S. Brodsky, Jason H. Downie, Edward
Herring, John R. Muse and Andrew Rosen) exercise, on behalf of Ultimate GP
and Sector Performance GP, voting and dispositive powers over the
securities held by Sector Performance
Fund.
|
|
(3)
|
HM
Unitek Coinvest, LP (“Coinvest”) is the direct beneficial owner of
13,319,640 shares of Common Stock, consisting of 13,319,640 shares of
Common Stock . Ultimate GP is the general partner of Coinvest
and, as a result, Ultimate GP may be deemed to share beneficial ownership
with respect to these securities. Except to the extent of any
pecuniary interests, Ultimate GP disclaims such beneficial
ownership. A six-person committee (consisting of Joe
Colonnetta, Peter S. Brodsky, Jason H. Downie, Edward Herring, John R.
Muse and Andrew Rosen) exercise, on behalf of Ultimate GP, voting and
dispositive powers over the securities held by
Coinvest.
|
|
(4)
|
SPF
SBS LP (“SPF”) is the direct beneficial owner of 6,217,924 shares of
Common Stock, consisting of (i) 5,525,574 shares of Common Stock, and
(ii) 692,350 shares of Common Stock issuable upon the conversion of 13,847
shares of Series B Preferred Stock. Ultimate GP is the general
partner of SPF and, as a result, Ultimate GP may be deemed to share
beneficial ownership with respect to these securities. Except
for pecuniary interests, Ultimate GP disclaims such beneficial
ownership. A six-person committee (consisting of Joe
Colonnetta, Peter S. Brodsky, Jason H. Downie, Edward Herring, John R.
Muse and Andrew Rosen) exercises, on behalf of Ultimate GP, voting and
dispositive powers over the securities held by
SPF.
|
|
(5)
|
No
securities are directly beneficially owned by Mr. Brodsky. Mr.
Brodsky holds a direct or indirect interest in Sector Performance Fund,
Coinvest, and SPF (collectively, the “Investment Funds”), which
beneficially own an aggregate of 117,949,650 shares of Common Stock on an
as-converted basis as explained in more detail below. Mr.
Brodsky is an executive officer and member of Ultimate GP. The
aggregate 117,949,650 shares of Common Stock are comprised as follows: (i)
106,300,100 shares of Common Stock held by the Investment Funds, and (ii)
11,649,550 shares of Common Stock issuable upon the conversion of 232,991
shares of the Series B Preferred Stock held by the Investment
Funds. Mr. Brodsky is a member of a six-person committee
(consisting of Mr. Brodsky, Joe Colonnetta, Jason H. Downie, Edward
Herring, John R. Muse and Andrew Rosen) that exercises, on behalf of
Ultimate GP, voting and dispositive powers over the securities held by the
Investment Funds. No single member of the committee has sole
dispositive and/or voting power over the securities held by the Investment
Funds. Mr. Brodsky may be deemed to beneficially own all or a
portion of the shares of Common Stock beneficially owned by the Investment
Funds; however, Mr. Brodsky disclaims beneficial ownership of the shares
of Common Stock, except to the extent of any pecuniary interest
therein.
|
|
(6)
|
No
securities are directly beneficially owned by Mr.
Colonnetta. Mr. Colonnetta holds a direct or indirect interest
in the Investment Funds, which beneficially own an aggregate of
117,949,650 shares of Common Stock on an as-converted basis as explained
in more detail below. Mr. Colonnetta is an executive officer
and member of Ultimate GP. The aggregate 117,949,650 shares of
Common Stock are comprised as follows: (i) 106,300,100 shares of Common
Stock held by the Investment Funds, and (ii) 11,649,550 shares of Common
Stock issuable upon the conversion of 232,991 shares of the Series B
Preferred Stock held by the Investment Funds. Mr. Colonnetta is
a member of a six-person committee (consisting of Mr. Colonnetta, Peter S.
Brodsky, Jason H. Downie, Edward Herring, John R. Muse and Andrew Rosen)
that exercises, on behalf of Ultimate GP, voting and dispositive powers
over the securities held by the Investment Funds. No single
member of the committee has sole dispositive and/or voting power over the
securities held by the Investment Funds. Mr. Colonnetta may be
deemed to beneficially own all or a portion of the shares of Common Stock
beneficially owned by the Investment Funds; however, Mr. Colonnetta
disclaims beneficial ownership of the shares of Common Stock, except to
the extent of any pecuniary interest
therein.
|
|
(7)
|
No
securities are directly beneficially owned by Mr. Hopkin. Mr.
Hopkin is an officer of Ultimate GP; however, in that role, Mr. Hopkin has
no voting or dispositive power over the securities held by the Investment
Funds.
|
|
(8)
|
Represents
7,522,964 shares directly held by the Old Berliner Liquidating Trust (the
“Trust”). The Trust owns 13,101,644 shares of Common Stock and
Mr. Berliner beneficially owns 57% of the Trust’s assets as a beneficiary
under the Trust.
|
|
(9)
|
The
Trust owns 13,101,644 shares of Common Stock. John X. Adiletta
is sole trustee of the Trust and has sole voting and dispositive power
over the securities held by the
Trust.
|
|
(10)
|
These
shares include (i) 4,489,795 shares of Common Stock held by Sigma
Opportunity Fund, LLC (“Sigma”); (ii) 2,170,407 shares of Common Stock
held by Sigma Berliner, LLC (“SBLLC”), an affiliate of Sigma; (iii)
1,334,587 shares of Common Stock, which includes 175,000 shares of Common
Stock issuable upon the exercise of warrants with an initial exercise
price of $0.55 per share, held by Sigma’s affiliate, Sigma Capital
Advisors, LLC (“Advisors”) and (iv) 25,000 shares of Common Stock held by
Thom Waye. Advisors, Sigma Capital Partners, LLC (“Partners”)
and Thom Waye may be deemed to be indirect 5% owners of the Company by
virtue of Advisors being the managing member of Sigma, Partners being the
sole member of Advisors and Mr. Waye being the sole member of
Partners. Mr. Waye, Advisors and Partners have disclaimed
beneficial ownership of the shares owned by Sigma and SBLLC except to the
extent of their pecuniary interest therein. The address of
each of Sigma, SBLLC, Advisors, Partners and Mr. Waye is c/o Sigma Capital
Advisors, LLC, 800 Third Avenue, Suite 1701, New York,
NY 10022. Information related to Sigma in this footnote is
based upon the Schedule 13D filed by Sigma on March 2,
2010.
|
|
(11)
|
Mr.
Hisey is the direct beneficial owner of 1,250,000 shares of Common Stock
(on an as-converted basis), consisting of (i) 1,200,000 shares of
Common Stock, and (ii) 50,000 shares of Common Stock issuable upon
the conversion of 1,000 shares of Series B Preferred
Stock. Also includes vested options to purchase 2,607,600
shares of Common Stock. 40% of these options become exercisable
only when the closing price per share of the Common Stock is equal to or
greater than $3.00 for twenty (20) consecutive trading days on which at
least 5,000 shares of Common Stock are traded, as reported on the
principal exchange on which the Common Stock is then
traded. Also includes warrants to purchase 218,750 shares of
Common Stock.
|
|
(12)
|
Mr.
Giacalone is the direct beneficial owner of 1,233,350 shares of Common
Stock, consisting of (i) 1,100,000 shares of Common Stock, and (ii)
133,350 shares of Common Stock issuable upon the conversion of 2,667
shares of Series B Preferred Stock. Also includes vested
options to purchase 1,200,000 shares of Common Stock. 40% of
these options become exercisable only when the closing price per share of
the Common Stock is equal to or greater than $3.00 for twenty (20)
consecutive trading days on which at least 5,000 shares of Common Stock
are traded, as reported on the principal exchange on which the Common
Stock is then traded.
|
|
(13)
|
Represents
vested options to purchase 400,000 shares of Common Stock. 40%
of these options become exercisable only when the closing price per share
of the Common Stock is equal to or greater than $3.00 for twenty (20)
consecutive trading days on which at least 5,000 shares of Common Stock
are traded, as reported on the principal exchange on which the Common
Stock is then traded.
|
|
(14)
|
Includes
(i) 75,000 shares of Common Stock, and (ii) 8,600 shares of Common Stock
issuable upon the conversion of 172 shares of Series B Preferred
Stock. Also includes vested options to purchase 607,575 shares
of Common Stock. 40% of these options become exercisable only
when the closing price per share of the Common Stock is equal to or
greater than $3.00 for twenty (20) consecutive trading days on which at
least 5,000 shares of Common Stock are traded, as reported on the
principal exchange on which the Common Stock is then
traded. Also includes warrants to purchase 40,650 shares of
Common Stock.
|
|
(15)
|
Represents
options to purchase 188,650 shares of Common Stock. 40% of
these options become exercisable only when the closing price per share of
the Common Stock is equal to or greater than $3.00 for twenty (20)
consecutive trading days on which at least 5,000 shares of Common Stock
are traded, as reported on the principal exchange on which the Common
Stock is then traded. Also includes warrants to purchase 5,000
shares of Common Stock.
|
|
|
(16)
|
Represents
options to purchase 520,000 shares of Common Stock. 40% of
these options become exercisable only when the closing price per share of
the Common Stock is equal to or greater than $3.00 for twenty (20)
consecutive trading days on which at least 5,000 shares of Common Stock
are traded, as reported on the principal exchange on which the Common
Stock is then traded.
|
|
(17)
|
Includes
(i) 25,000 shares of common stock, (ii) warrants to purchase 5,000 shares
of common stock, and (iii) vested options to purchase 470,380 shares of
common stock. 40% of these options become exercisable only when
the closing price per share of the Common Stock is equal to or greater
than $3.00 for twenty (20) consecutive trading days on which at least
5,000 shares of Common Stock are traded, as reported on the principal
exchange on which the Common Stock is then traded.
|
|
|
(18)
|
Includes
vested options to purchase 135,000 shares of Common Stock. Also
includes 30,696 shares of Common Stock held by the Trust for which Mr. Day
is the beneficiary. Excludes the remainder of the securities held by the
Trust, in which Mr. Day disclaims all beneficial
ownership.
|
|
(19)
|
Mr.
MacDonald is the direct beneficial owner of 607,300 shares of Common
Stock, consisting of (i) 500,000 shares of Common Stock, and
(ii) 57,300 shares of Common Stock issuable upon the conversion of
1,146 shares of Series B Preferred Stock. Also includes vested
options to purchase 50,000 shares of Common Stock. 40% of these
options become exercisable only when the closing price per share of the
Common Stock is equal to or greater than $3.00 for twenty (20) consecutive
trading days on which at least 5,000 shares of Common Stock are actually
traded, as reported on the principal exchange on which the Common Stock is
then traded.
|
|
(20)
|
Includes
54,166 shares of Common Stock and vested options to purchase 50,000 shares
of Common Stock.
|
|
(21)
|
Represents
options to purchase 50,000 shares of Common
Stock.
|
|
(22)
|
Represents
options to purchase 527,500 shares of Common
Stock.
|
|
(23)
|
Includes
25,000 shares of Common Stock and vested options to purchase 50,167 shares
of Common Stock.
|
|
(24)
|
Thom
Waye may be deemed to be an indirect owner of the shares held by Sigma by
virtue of Mr. Waye being the manager of Sigma. Mr. Waye has disclaimed
beneficial ownership of the shares owned by Sigma except to the extent of
his pecuniary interest therein. Includes 25,000 shares of Common Stock
owned directly by Mr. Waye.
|
|
(25)
|
Includes
Peter Brodsky, Joe Colonnetta, Daniel Hopkin, Peter Giacalone, C. Scott
Hisey, Richard B. Berliner, Mark S. Dailey, Richard Siber, Dean MacDonald,
Dan Yannantuono, Chris Perkins, Ronald Lejman, Raymond A.
Cardonne, Jr., Michael S. Guerriero, Peter Mixter, Mehran Nazari, John
Stevens Robling, Jr., Thom Waye and Nicholas
Day.
|
|
(26)
|
Consists
of (i) 124,756,881 shares of Common Stock, (ii) 11,901,700 shares of
Common Stock issuable upon the conversion of 238,034 shares of Series B
Preferred Stock, (iii) warrants to purchase 444,400 shares of Common
Stock, and (iv) vested options to purchase 6,957,039 shares of Common
Stock.
|
|
By
Order of the Board of Directors
|
|
|
/s/ Peter Giacalone
|
|
|
Peter
Giacalone
Chairman
of the Board
|
|
|
October 29, 2010
|
|
C.
Scott Hisey
|
|
|
Chief
Executive Officer
|